NCT00336635View on ClinicalTrials.gov

Safety and Immunogenicity of CJ-50300

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

February 28, 2007

Conditions

Smallpox

Interventions

BIOLOGICAL

cell-culture derived smallpox vaccine

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

HK inno.N Corporation

All Listed Sponsors

collaborator

HK inno.N Corporation

INDUSTRY

lead

Seoul National University Hospital

OTHER